IL-10-producing regulatory cells impact on celiac disease evolution

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• Celiac disease (CD) is an immune-mediated enteropathy triggered by gluten ingestion.
• The precise mechanisms driving CD progression and immune dysregulation remain incompletely understood.
• Understanding T-cell responses and regulatory mechanisms is vital for managing CD.

Purpose of the Study:

• To investigate immune cell composition, cytokine profiles, and T-cell responses to gliadin in patients with potential and acute celiac disease.
• To elucidate the role of IL-10 producing cells in controlling gluten-specific T-cell responses.
• To identify potential biomarkers for early detection of celiac disease.

Main Methods:

• Analysis of immune cell populations and plasma cytokines in patients with potential-CD, acute-CD, and controls.
• Assessment of gliadin-specific T-cell responses, including IFN-γ and IL-10 secretion.
• Evaluation of T-cell responses following IL-10 inhibition and during a gluten-free diet (GFD).

Main Results:

• CD patients exhibited an inflammatory signature and circulating gliadin-specific IFN-γ+ T cells, irrespective of mucosal damage.
• Potential-CD patients showed increased frequencies of gut IL-10-secreting dendritic cells (DC-10) and circulating gliadin-specific IL-10+ T cells.
• IL-10 inhibition enhanced IFN-γ secretion, indicating its suppressive role. On GFD, inflammation resolved, but IL-10+ T cells accumulated in the gut.

Conclusions:

• IL-10-producing cells, especially DC-10, are essential for controlling pathological T-cell responses to gluten.
• DC-10 play a protective role in the intestinal mucosa and are a potential biomarker for potential-CD.
• Targeting IL-10 pathways may offer therapeutic strategies for celiac disease management.